Testing effectiveness (Phase 2)Not Yet RecruitingNCT07407452
What this trial is testing
Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer
Who this might be right for
Ovarian Cancers
Jiangsu Cancer Institute & Hospital 50